A Study to Assess the Concentrations of Risankizumab in the Breast Milk of Adult Lactating Women With Inflammatory Bowel Disease
NCT06346288
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
10
Enrollment
INDUSTRY
Sponsor class
Conditions
Inflammatory Bowel Disease
Interventions
PROCEDURE:
Breast Milk Sampling
DRUG:
Risankizumab
Sponsor
AbbVie